Title |
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
|
---|---|
Published in |
Digestive Diseases and Sciences, December 2014
|
DOI | 10.1007/s10620-014-3486-7 |
Pubmed ID | |
Authors |
Maria Buti, Naoky Tsai, Joerg Petersen, Robert Flisiak, Selim Gurel, Zahary Krastev, Raul Aguilar Schall, John F. Flaherty, Eduardo B. Martins, Prista Charuworn, Kathryn M. Kitrinos, G. Mani Subramanian, Edward Gane, Patrick Marcellin |
Abstract |
Long-term tenofovir disoproxil fumarate (TDF) treatment for chronic hepatitis B (CHB) is associated with sustained viral suppression and regression of fibrosis and cirrhosis at year 5 (240 weeks) and no TDF resistance through 6 years (288 weeks). |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 130 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 24 | 18% |
Other | 17 | 13% |
Student > Master | 17 | 13% |
Student > Ph. D. Student | 11 | 8% |
Student > Bachelor | 8 | 6% |
Other | 14 | 11% |
Unknown | 39 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 53 | 41% |
Biochemistry, Genetics and Molecular Biology | 12 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 8% |
Agricultural and Biological Sciences | 4 | 3% |
Nursing and Health Professions | 3 | 2% |
Other | 8 | 6% |
Unknown | 40 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2021.
All research outputs
#4,309,113
of 23,854,458 outputs
Outputs from Digestive Diseases and Sciences
#585
of 4,304 outputs
Outputs of similar age
#58,276
of 358,993 outputs
Outputs of similar age from Digestive Diseases and Sciences
#9
of 67 outputs
Altmetric has tracked 23,854,458 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,304 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,993 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.